BioNTech SE - ADR vs Paycom Software Inc — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Paycom Software Inc trades at $211 (market cap $9.57B). The key difference: BioNTech SE - ADR is far larger — about 2.4× Paycom Software Inc's market cap, and Paycom Software Inc pays a 0.71% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | PAYC | |
|---|---|---|
Market Cap | $23.31B | $9.57B |
Sector | Health | Technology |
52-Week High | $119.34 | $233.89 |
52-Week Low | $83.89 | $113.59 |
Enterprise Value | $6.60B | $10.35B |
Dividend Yield | — | 0.71% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →